Grant: Doctoral Research Award: Canada Graduate Scholarships
Université de Montréal
$105,000.00
Improving ataxia molecular diagnosis through second and third generation sequencing data integration: A pilot study on a cohort of patients with complex unresolved ataxias
EF 2023-24
Résumé
Advances in genetics research are highly driven by technological innovations, most recently benefiting from the development of efficient high-volume sequencing approaches. Diagnosis and understanding of rare neurological disorders, which are clinically and genetically complex, have greatly benefited from these innovative technologies. However, there is still many patients left without an official genetic diagnosis or for whom we don't understand how the disease affects their body despite a diagnosis, representing important obstacles for care management and therapy research. To address these challenges, it is essential to combine different approaches.
The proposed project aims to define a multi-technology approach to improve our ability to provide a diagnosis based on genetic information. More concretely, we focus on ataxias, a group of clinically variable disorders affecting body coordination which often present with a late-onset and worsen over time. Hence, blood samples from a group of patients with complex ataxias were used to perform a combination of DNA and RNA sequencing that served to identify specific genetic variations that could explain the disease for each participant.
Multiple candidates are already well on their way to be experimentally validated as causes of our patients' disorders. To that regard, a third sequencing approach, which generates longer bits of genetic information, serves as the key tool for the validation. Indeed, long-read sequencing offers a versatile and very relevant set of applications to assess the biological effects of mutations. We're also generating cellular models that are representative of our patient's brain cells for more accurate assessments of the more complicated candidates.
This project will lead to the discovery of new ataxia causes, which will help geneticists to accurately diagnose future patients. It will also contribute more broadly to our knowledge of how these disease genes work and how they cause the disease.
Programme
Doctoral Research Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
496926
Name
Audet Sébastien
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Doctoral Research Awards - B
Projecttitle
Improving ataxia molecular diagnosis through second and third generation sequencing data integration: A pilot study on a cohort of patients with complex unresolved ataxias
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Applied Genetics; Ataxia; Bioinformatics; Diagnostic Tools; Functional Validation; Genomics; Long-Read Sequencing; Rna Sequencing; Transcriptomics; Whole Genome Sequencing
Abstract
Advances in genetics research are highly driven by technological innovations, most recently benefiting from the development of efficient high-volume sequencing approaches. Diagnosis and understanding of rare neurological disorders, which are clinically and genetically complex, have greatly benefited from these innovative technologies. However, there is still many patients left without an official genetic diagnosis or for whom we don't understand how the disease affects their body despite a diagnosis, representing important obstacles for care management and therapy research. To address these challenges, it is essential to combine different approaches.
The proposed project aims to define a multi-technology approach to improve our ability to provide a diagnosis based on genetic information. More concretely, we focus on ataxias, a group of clinically variable disorders affecting body coordination which often present with a late-onset and worsen over time. Hence, blood samples from a group of patients with complex ataxias were used to perform a combination of DNA and RNA sequencing that served to identify specific genetic variations that could explain the disease for each participant.
Multiple candidates are already well on their way to be experimentally validated as causes of our patients' disorders. To that regard, a third sequencing approach, which generates longer bits of genetic information, serves as the key tool for the validation. Indeed, long-read sequencing offers a versatile and very relevant set of applications to assess the biological effects of mutations. We're also generating cellular models that are representative of our patient's brain cells for more accurate assessments of the more complicated candidates.
This project will lead to the discovery of new ataxia causes, which will help geneticists to accurately diagnose future patients. It will also contribute more broadly to our knowledge of how these disease genes work and how they cause the disease.
Competitiondate
202311
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Audet, Sébastien
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~